Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BridgeBio Pharma is a US-based biopharmaceutical company focused on the discovery, development, and delivery of therapies for rare genetic diseases. The company aims to sustainably improve the quality of life for patients with high unmet medical needs and offer them new hope through innovative drug development.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BridgeBio Pharma is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BridgeBio Pharma last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.78 USD.
Across its last 3 earnings reports, BridgeBio Pharma stock moved by ±2.5% on average the following day. The largest reaction was -4.9% on 10/29/2025; 0 of 3 reactions were positive.
BridgeBio Pharma has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.